x
Norris Cotton Cancer CenterNorris Cotton Cancer Center
In This Section

Melanoma / Skin Cancer Program Clinical Trials

A clinical trial is one of the final steps in a long and careful cancer research process that is looking for better ways to prevent, diagnose, or treat cancer. Clinical trials test new medical approaches in patients with cancer, and are important to developing new treatments for cancer. Many of the "standard treatments" that patients with cancer receive today were developed based on the results of previous clinical trials.

The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.

Kaposis sarcoma Clinical Trials
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Kaposis sarcoma
FED11061
Pace
Melanoma, skin Clinical Trials
A PHASE III RANDOMIZED TRIAL COMPARING PHYSICIAN/PATIENT CHOICE OF EITHER HIGH DOSE INTERFERON OR IPILIMUMAB TO MK-3475 (PEMBROLIZUMAB) IN PATIENTS WITH HIGH RISK RESECTED MELANOMA
Melanoma, skin
S1404
Shirai
A Randomized Phase II Trial of Ipilimumab with or Without Bevacizumab in Patients with Unresectable Stage III or Stage IV Melanoma
Melanoma, skin
E3612
Arrick
Immunologic Evaluation of Peripheral Blood
Melanoma, skin
D0229
Lewis
Phase III Randomized Study of Four Weeks High Dose IFN-�2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-4, N1a, 2a (microscopic) Melanoma
Melanoma, skin
E1697
Arrick
Phase IIIb/IV, Randomized, Double Blinded, Study of Nivolumab 3 mg/kg in Combination with Ipilimumab 1 mg/kg vs Nivolumab 1 mg/kg in Combination with Ipilimumab 3 mg/kg in Subjects with Previously Untreated, Unresectable or Metastatic Melanoma
Melanoma, skin
F16088
Shirai
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Melanoma, skin
EA6141
Shirai
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Melanoma, skin
FED11061
Pace
Renal Tumor Tissue Bank
Melanoma, skin
D1013
Seigne
Other Skin Clinical Trials
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Skin
FED11061
Pace

0